Latest News about BIIB

Recent news which mentions BIIB

...

26 27 28 29 30 31 32 33 Next >

Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022

March 08, 2022

10 Biggest Price Target Changes For Tuesday

March 08, 2022

As President Biden proposed, Medicare needs the ability to negotiate drug prices

March 07, 2022

The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan

March 04, 2022

Why This Analyst Sees Roughly 20% Upside In This Large-Cap Biopharma

March 03, 2022

Expert Ratings For Biogen

March 03, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022

March 03, 2022

10 Biggest Price Target Changes For Thursday

March 03, 2022

Viatris stock slides 24% as analysts say sale of biosimilars to Indian partner removes key growth driver

February 28, 2022

Medicare’s finances and the saga of the Alzheimer’s drug Aduhelm

February 24, 2022

What Investors Can Learn From Biogen's Drug Approval That No One Wants

February 23, 2022

Could Advocacy Groups' Campaign for Aduhelm Benefit Biogen?

February 19, 2022

Stocks That Hit 52-Week Lows On Thursday

February 17, 2022

Sage Therapeutics - Biogen Partnered Depression Drug Meets Main Goal In Late-stage Study

February 16, 2022

US Senate Narrowly Votes In Favor Of Biden's Nominee Robert Califf To Lead FDA For Second Time

February 16, 2022

3 Red Flags for Biogen's Future

February 16, 2022

The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa

February 16, 2022

3 Cutting-Edge, Protein-Degrader Biotech Stocks to Watch

February 16, 2022

What to Expect From Biogen's $2.3 Billion Shopping Spree

February 12, 2022

2 High-Yield Dividend Stocks That Are Trading Near Their 52-Week Lows

February 10, 2022

2 Reasons to Buy Biogen, 1 Reason to Sell

February 10, 2022

Biogen-Xbrane Enter License Agreement For Cimzia Referenced Biosimilar, Xcimzane

February 08, 2022

The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar

February 08, 2022

10 Biggest Price Target Changes For Monday

February 07, 2022

The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More

February 06, 2022

Biogen's Aduhelm Approval, Marketing Comes Under FTC, SEC Probes

February 04, 2022

What 24 Analyst Ratings Have To Say About Biogen

February 04, 2022

Analyst Ratings For Biogen

February 04, 2022

Benzinga's Top Ratings Upgrades, Downgrades For February 4, 2022

February 04, 2022

10 Biggest Price Target Changes For Friday

February 04, 2022

...

26 27 28 29 30 31 32 33 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.